Abstract:Objective:To evaluate the clinical value of metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid in acquired immune deficiency syndrome (AIDS)? complicated with central nervous system (CNS) infection, and to investigate the pathogetic spectrum.Methods:AIDS patients complicated with CNS infection in Zhongnan Hospital of Wuhan University from January 2021 to August 2022 were analyzed, including the clinical characteristics and pathogen information detected by mNGS and routine etiological examination. The pathogens detected by routine etiological examination and mNGS were compared, and the consistency with clinical diagnosis was evaluated.Results:Among the 61 patients with CNS infection, 60 patients (98.4%, 60/61) were identified by mNGS combined with routine etiological examination, which was significantly higher than that of routine etiological examination alone (49.2%, 30/61) and that of mNGS alone (83.6%, 51/61), with significant differences (χ2 = 38.125, P < 0.001; χ2 = 8.093, P = 0.004). The positive rate of mNGS 83.6% (51/61) was significantly higher than that of routine etiological examination [49.2% (30/61)], with significant difference (χ2 = 16.201, P < 0.001). The detection rate of two or more pathogens by mNGS was 41.0% (25/61), which was significantly higher than that by routine etiological examination (9.8%, 6/61), with significant difference (χ2 = 15.612, P < 0.001). For the detection rate of cryptococcal meningitis, conventional detection method [14.8% (9/61)] was in good agreement with mNGS [13.1% (8/61)], and the consistency with clinical diagnosis were 90% (9/10) and 80% (8/10), respectively. At least one virus was detected in 43 (70.5%) patients, of which 24 (39.3%) cases detected human herpesvirus 4 (EBV), 15 (24.6%) cases detected human herpesvirus 5 (CMV), and 8 (13.1%) cases detected JC polyomavirus. Total of 18 strains of fungi were detected in 14 (23.0%) patients, including 8 strains of Cryptococcus neoformans, 4 strains of Aspergillus, 3 strains of Candida parapsilosis, 1 strain of Talaromyces marneffei, 1 strain of Pneumocystosis jirovecii and 1 strain of Dosporium apiospermum. There were 8 (13.1%) atypical pathogens detected, including 3 strains of Toxoplasma gondii, 3 strain of Treponema pallidum, 1 strain of Legionella and 1 strain of Rickettsia felis. Tuberculosis and non-tuberculous mycobacterium were detected in 2 (6.6%) cases respectively. Total of 3 cases died, the mortality rate was 4.9% (3/61).Conclusions:Mixed infections are common in advanced AIDS patients complicated with CNS infection, and the pathogetic spectrum includes virus, fungi, bacterial and atypical pathogens. mNGS combined with routine etiological examination could significantly improve the rapid pathogen detection rate of intracranial infections and the survival rate of patients.

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China

Case Report: Streptococcus Suis Meningitis Diagnosed in a HIV-Infected Patient with Cryptococcal Meningitis Using Next-Generation Sequencing

Metagenomic next-generation sequencing for identification of central nervous system pathogens in HIV-infected patients

Molecular diagnosis of opportunistic infections in the central nervous system of HIV-infected adults in Manaus, Amazonas

Metagenomic next-generation sequencing versus traditional laboratory methods for the diagnosis of central nervous system opportunistic infections in HIV-infected Chinese adults

Clinical application of metagenomic next-generation sequencing in patients with acquired immune deficiency syndrome complicated with central nervous system infection

Nanopore targeted sequencing-based diagnosis of central nervous system infections in HIV-infected patients

Microbiomes detected by cerebrospinal fluid metagenomic next‐generation sequencing among patients with and without HIV with suspected central nervous system infection

Clinical Usefulness of Metagenomic Next-Generation Sequencing for the Diagnosis of Central Nervous System Infection in People Living with HIV.

Clinical analysis on the 57 AIDS patients complicated with central nervous system lesions

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

Epidemiology and Clinical Characteristics of Cryptococcal Meningitis in China

The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study

HIV Infection Does Not Increase 10-Week Mortality of Chinese Cryptococcal Meningitis Patients

Disease Spectrum and Prognostic Factors of 499 Cases of Acquired Immune Deficiency Syndrome Complicated with Central Nervous System Infections in Chongqing

Clinical characteristics and prognostic factors of 60 patients with acquired immune deficiency syndrome combined with Cryptococcus neoformans

Clinical characteristics, Cryptococcus neoformans genotypes, antifungal susceptibility, and outcomes in human immunodeficiency virus-positive patients in Beijing, China

Molecular identification and genetic characteristics of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi in human immunodeficiency virus/acquired immunodeficiency syndrome patients in Shanghai, China

Understanding Etiology of Community-Acquired Central Nervous System Infections Using Metagenomic Next-Generation Sequencing

Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients

Performance of Metagenomic Next-Generation Sequencing for the Diagnosis of Cryptococcal Meningitis in HIV-Negative Patients